A股6G概念股拉升，创远信科、硕贝德涨超10%，陕西华达涨超8%，广哈通信、通宇通讯跟涨。 ...

Summary of Conference Call Records Company Overview - **Company Name**: Chuangyuan Xinke (创远信科) - **Established**: 2005 - **Focus**: Development of wireless communication and RF microwave testing instruments and solutions - **2024 Revenue**: 230 million CNY - **Patents**: 526 domestic and international patents - **Employees**: Approximately 230 - **R&D Centers**: Four located in Shanghai, Nanjing, Chengdu, and Zhuhai - **Stock Code**: 831,961 [2][3] Industry Focus - **Core Industry**: RF communication instruments - **Key Areas of Application**: - 5G/6G wireless communication - Vehicle networking (V2X) - Low Earth orbit (LEO) satellite and low-altitude communication [1][3] Strategic Insights - **Development Strategy**: Adopts a "1+3" strategy focusing on high-end wireless communication testing instruments applied in three areas: 5G/6G, vehicle networking, and low Earth orbit satellite communication [1][3][4]. - **Technological Advancements**: Plans to enhance vector network analyzers to 110GHz and eventually to 500GHz and terahertz bands, participating in 6G standard formulation as an IMT-2030 member [4][16]. - **Awards**: Received the National Science and Technology Progress Award (second prize) for microwave and millimeter-wave testing technology in 2023 [11]. Market Trends - **Vehicle Networking**: Increasing demand for high bandwidth and interference resistance in vehicle internal networks, with protocols like C-V2X and EUHT playing significant roles [1][6]. - **Low Earth Orbit Satellite Internet**: Projects like Starlink and China's Xingwang aim to provide ground broadband mobile internet access, integrating with future 6G technology [1][7]. - **Testing Instrument Importance**: Essential across various industries, supporting advancements in 5G/6G, vehicle networking, and low Earth orbit satellite internet [5]. Competitive Landscape - **Positioning**: Chuangyuan Xinke holds a significant position in the RF instrument industry but still lags behind global leaders like Keysight and Rohde & Schwarz [18]. - **Market Opportunities**: The trade war has created opportunities for domestic companies to replace imports, potentially increasing market share [18]. Research and Development - **Investment**: Over 100 million CNY annually in R&D, totaling 500 million CNY over the past three years [25]. - **Intellectual Property**: Holds 526 patents, with 68% being invention patents, including international patents [25]. Future Outlook - **6G Development**: 6G standards expected to be frozen by 2027 and commercialized by 2030, with Chuangyuan actively involved in R&D [29]. - **Low Altitude Economy**: Anticipated growth in demand for RF instruments as low-altitude operations expand, particularly with the integration of drones and autonomous vehicles [38]. Key Products and Solutions - **Core Products**: Includes signal sources, signal analyzers, channel simulators, and vector network analyzers, with a focus on comprehensive testing solutions for vehicle networking and satellite communication [14][15]. - **OTA Testing Solutions**: Developed for vehicle networking and intelligent driving, providing reliable data link support [15][17]. Conclusion Chuangyuan Xinke is strategically positioned in the RF communication instrument industry, focusing on high-end testing solutions for emerging technologies like 5G/6G and low Earth orbit satellites. The company is committed to innovation and has a robust R&D framework, aiming to capitalize on market opportunities while navigating competitive challenges.

证券代码：831961 证券简称：创远信科 公告编号：2025-033 创远信科（上海）技术股份有限公司 关于取得专利证书的公告 上述专利证书的取得，有利于增强公司对知识产权的保护力度， 进一步完善知识产权保护体系，发挥自主知识产权优势，促进公司持 一、基本情况 2025 年 4 月 25 日，创远信科（上海）技术股份有限公司（以下 简称"公司"或"创远信科"）收到了由国家知识产权局下发的 1 项 《发明专利证书》。具体情况如下： | 专利类型 | 专利名称 | 专利号 | | --- | --- | --- | | | 实现可级联多功能射频矢量收发测试的系 | | | 发明 | | ZL 202211595120.1 | | 统 | | | 截至本公告日止，创远信科及其合并报表范围内子公司累计申请 国内外专利 525 项，其中发明专利 360 项，占比 68.57%，授权专利 302 项，其中发明专利 157 项，实用新型专利 106 项，外观设计专利 39 项。 二、对公司影响 续技术创新，提升公司的核心竞争力，助力业务快速发展。 三、风险提示 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚 ...

Core Insights - The company won the 2023 National Science and Technology Progress Award (Second Class), marking a significant milestone after previously winning the Special Class Award in 2016 [2] - In 2024, the company reported a revenue of 233 million yuan and a net profit attributable to shareholders of 12.46 million yuan [2] - The company continues to implement its optimized "1+3" development strategy, focusing on wireless communication testing, automotive electronics, and satellite internet testing [2] Financial Performance - The company achieved a revenue of 233 million yuan in 2024 [2] - The net profit attributable to shareholders was 12.46 million yuan [2] - Research and development expenditure for the year was 104 million yuan, accounting for 44.63% of total revenue [3] Product Development and Innovation - The company launched several new products, including mmWave 5G integrated testing systems and low Earth orbit satellite internet multi-terminal testing instruments [3] - Two major national R&D projects were completed, leading to breakthroughs in key technologies and the development of advanced testing instruments [3] - The company has applied for 512 patents, including 352 invention patents, and has successfully obtained 300 authorized patents [5] Infrastructure and Talent Development - The first phase of the G60 Science and Technology Innovation Corridor headquarters was completed, aiming to create a comprehensive future technology headquarters [4] - The company announced a 2025 employee stock ownership plan with a maximum of 15.26 million shares [4] - The company is focused on talent development and building a high-level team [4]

证券代码：831961 证券简称：创远信科 公告编号：2025-009 创远信科（上海）技术股份有限公司 2024 年独立董事述职报告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 饶钢先生作为创远信科（上海）技术股份有限公司（以下简称"创 远信科"或"公司"）第七届董事会独立董事和审计委员会主任，在 2024年任职期间严格按照《中华人民共和国公司法》（"《公司法》"）、 《北京证券交易所上市公司持续监管办法（试行）》、《北京证券交易 所股票上市规则（试行）》（"《上市规则》"）、《北京证券交易所上 市公司持续监管指引第 1 号——独立董事》（"《监管指引》"）、中 国证券监督管理委员会（"中国证监会"）颁布的《上市公司治理准 则（2018 修订）》等相关规定以及《创远信科（上海）技术股份有限 公司章程》（"公司章程"）、《独立董事工作细则》的规定和要求， 在 2024 年度工作中，充分发挥独立董事的作用，勤勉尽责，及时关 注公司经营发展情况，积极出席相关会议，认真审议董事会各项议案， 并对重大事项发 ...

3、公司本次员工持股计划拟参加对象符合《指导意见》及其他 法律、法规和规范性文件规定的参加条件，符合本次员工持股计划规 定的参加对象范围，其作为公司本次员工持股计划参加对象的主体资 格合法、有效。 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 创远信科（上海）技术股份有限公司（以下简称"公司"）监事 会依据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人 民共和国证券法》（以下简称"《证券法》"）、《关于上市公司实施员工 持股计划试点的指导意见》（以下简称"《指导意见》"）、《北京证 券交易所上市公司持续监管指引第 3 号——股权激励和员工持股计 划》（以下简称"《监管指引》"）等法律法规和《创远信科（上海） 技术股份有限公司章程》（以下简称"《公司章程》"）的规定，对公司 《2025 年员工持股计划（草案）》及其摘要等相关文件进行了核查， 经全体监事充分讨论，发表如下意见： 1、公司不存在《指导意见》、《监管指引》等法律法规、部门规 章、规范性文件和《公司章程》规定的禁止实施员工持股计划 ...

证券代码：831961 证券简称：创远信科 公告编号：2025-019 创远信科（上海）技术股份有限公司 监事会关于 2023 年股票期权激励计划 注销部分股票期权议案的核查意见 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 创远信科（上海）技术股份有限公司（以下简称"公司"）监事 会依据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人 民共和国证券法》（以下简称"《证券法》"）、《创远信科（上海）技术 股份有限公司章程》（以下简称"《公司章程》"）、《上市公司股权激励 管理办法》（以下简称"《管理办法》"）、《北京证券交易所上市公 司持续监管指引第 3 号——股权激励和员工持股计划》（以下简称 "《持续监管指引 3 号》"）等法律法规以及公司《2023 年股票期权 激励计划》（以下简称"《股票期权激励计划》"）的规定，对公司《关 于 2023 年股票期权激励计划注销部分股票期权的议案》进行了核查， 发表了如下意见： 本次注销部分股票期权符合《管理办法》、《持续监管指引 3 号》、《股票期 ...

证券代码：831961 证券简称：创远信科 公告编号：2025-018 创远信科（上海）技术股份有限公司 关于 2023 年股票期权激励计划 注销部分股票期权的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 创远信科（上海）技术股份有限公司（以下简称"公司"）拟注销 《2023 年股票期权激励计划》部分股票期权共 4,110,090 份，根据 《上市公司股权激励管理办法》（以下简称"《管理办法》"）、《北京证 券交易所上市公司持续监管指引第 3 号——股权激励和员工持股计 划》（以下简称"《持续监管指引 3 号》"）等法律法规以及公司《2023 年股票期权激励计划》（以下简称"《股票期权激励计划》"）的规定， 现将有关事项说明如下： 一、本次股票期权注销审议及表决情况 2025 年 4 月 23 日公司召开第七届董事会第十六次会议审议通过 了《关于 2023 年股票期权激励计划注销部分股票期权的议案》，议案 表决结果：同意 7 票；反对 0 票；弃权 0 票。董事陈向民先生为本次 激励计划的激励对 ...

Financial Performance - The company's basic earnings per share decreased by 62.5% from 0.2400 yuan in 2023 to 0.0900 yuan in 2024 [1] - Operating revenue fell by 13.7%, from 2.7 billion yuan in 2023 to 2.33 billion yuan in 2024 [1] - Net profit dropped by 64.71%, from 0.34 billion yuan in 2023 to 0.12 billion yuan in 2024 [1] - Return on equity decreased significantly by 63.99%, from 4.61% in 2023 to 1.66% in 2024 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 29.0869 million shares, accounting for 27.58% of the circulating shares, a decrease of 10.2517 million shares from the previous period [1] - New entrants among the top shareholders include Li Jinhai, Xu Weiliang, Wang Xiaoxia, and Chen Xiangmin, while Shanghai Dongyuan Real Estate Development Group, Chuangjin Hexin Fund Management, Yang Xiaquan, and Jiangsu Jiquan Yuanhe Puhua Equity Investment Partnership exited the top ten [2] Dividend Distribution - The company announced a dividend distribution of 0.5 yuan per share (including tax) [3]

北京大成(上海)律师事务所 关于 创远信科(上海)技术股份有限公司 2023 年股票期权激励计划注销部分股票期权相关事宜 之 法律意见书 大成 is Dentons' Preferred Law Firm in China. | 卒 Ｖ ・ | | --- | | 正文 . | | 本次注销已履行的批准与授权 . | | l 本次注销相关事宜的具体情况 | | 分论 | \ , ' ' / ' / ' / ' / ' / ' / - 北京大成(上海)律师事务所 www.dachenglaw.com 上海市浦东新区世纪大道 100号上海环球金融中心 9/24/25 楼(200120) 9th/24th/25th Floor, Shanghai World Financial Center, No. 100 Century Avenue, Pudong New Area, Shanghai 200120, P.R. China Tel: +86 21-58785888 Fax: +86 21-58786866 大成DENTONS 大成 is Dentons' Preferred Law Firm in China ...